Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma: an indirect treatment comparison
Article in Leukemia & Lymphoma (February 2024)
The most recent citing publications are shown below. View all 109 publications that cite this research output on Dimensions.
Article in Leukemia & Lymphoma (February 2024)
Article in Blood Advances (January 2024)
Article in Molecular and Clinical Oncology (November 2023)